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ABSTRACT:  
Oncothermia (OTM) is based on electromagnetic interactions with the living 
matter. Its nano-targeting approach establishes a new paradigm. OTM could be 
applied not only to treat malignancies but it is feasible to apply for other diseases 
too. OTH is well proven method from the laboratory level to the clinical 
applications, promoting the natural processes, re-establishing of the 
synchronization between the cells. This approach allows therapy of some non-
malignant diseases too. Our objective is to use OTM for the irregularities of 
tissue-growth and for pain syndromes as well. OTM uses precisely tuned 
radiofrequency (RF) current flowing through the treated part of the body. We 
made extensive study, proving in details the applicability of the OTM for 
Dupuytren's contracture and chronic low back pain, in conjunction with 
permanent acupuncture method, a modified process of traditional Chinese 
Medicine (TCM). The synergy of the ancient and the state-of-art medical 
knowledges is the basic method of the present research. Our results with 
application of OTM for chronic low back pain and Dupuytren’s contracture shows 
definite improvements of the patients involved in the study. We measured the 
success with the Visual Analog Scale (VAS), with anecdotic quality of life (QoL), 
and the shortening of the of-work period due to the disease. We measured that 
VAS decreased significantly, the hand contracture became less rigid and less 
contracted. The QoL of patients improved and their complaints which blocked 
their regular activity has significantly reduced. OTM method was safe & no 
adverse effects were observed. Recognition of the distortions in the healthy tissue 
have some common principles and possibilities in TCM and OTM: both the 
methods recognize the loss of complexity of the living organization. Data of our 
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recent study verified the relevant end-points of our present study: the safety, the 
quality of life (QoL), the prolonged painless status of the patient.  
 
Keywords: Physiotherapy, Oncothermia, Dupuytren’s contracture, Non-specific 
low back pain  
 
 
INTRODUCTION   
 
Oncothermia (OTM) is a kind of hyperthermia method intended to use of malignant diseases, [1]. 
OTM is based on electromagnetic interactions with the living matter, selecting the malignant 
cells as targets, [2]. The membrane structure of malignant cells absorbs the provided 
electromagnetic energy, and controlled signal pathways are excited. This kind of nano-targeting 
approach establishes a new paradigm, [3]; which was successfully applied for various 
malignancies [4], which could be applied not only in case of malignancies but other diseases too. 
When the tissue is not malignant, but partly could be selected by the radiofrequency (RF) current 
OTM does effect to repair the irregularities as proliferation of non-malignant tissues.  [5]. OTM 
method is well proven from the laboratory level to the clinical applications, [6]. It ignites the 
natural processes supporting the homeostasis of the system, re-establishing the communication 
harmony between the cells. This is the reason of our present applications to treat some non-
malignant diseases.  
 
OTM was successfully applied previously for Lyme-disease, [7] for low-back pain, [8] for 
Peyronie disease, [9] and for Dupuytren's contracture, [10] too. The number of patients was a 
small one in these studies above. Therefore, we made a more extensive study, proving in details 
the applicability of the OTM for two of these diseases, the Dupuytren's contracture and the 
chronic low back pain. Dupuytren’s contracture: (also known as Morbus Dupuytren’s, or 
Dupuytren's disease and slang terms "Viking disease" or "Celtic hand”), is a fixed flexion 
contracture of the hand. It is named after Baron Guillaume Dupuytren, the surgeon who 
described an operation to correct the affliction in the Lancet in 1831. The Dupuytren’s 
contracture is a palmar fibromatosis, where the fingers bend towards the palm and cannot be 
fully extended (straightened). The ring finger and little finger are most commonly affected. The 
middle finger may be affected in advanced cases, but the index finger and the thumb are more 
rarely involved. It is an inherited proliferative connective tissue disorder that involves the hand's 
palmar fascia. Dupuytren's contracture progresses slowly and is often accompanied by some 
aching and itching. In patients with this condition, the palmar fascia thickens and shortens so that 
the tendons connected to the fingers cannot move freely. Incidence increases after age 40; at this 
age, men are affected more often than women. Beyond age of 80 the gender distribution is 
approx. even. Operation can improve the progressive situation in stage N0, N1. (N0, N1, N2 are 
the most common known stages of disease sorted according its development. N0: starting 
bending of finger, N1: more improvement fibromatosis, bending is significantly much more 
without extension ability, N2: no extension of finger anymore, serious fibromatosis) they are  
and other alternative therapies can be tried, like Quercetin, Bromelain, DMSO (Dimethyl	  
Sulfoxide), MSM (Methylsulfonylmethane)  Acetylcarnitin HCl, PABA (Para-amino-bensoic-acid), 
Nattokinase, Vitamin E Copper, Vitamin C, massage. The palmar fascia becomes hyperplastic 
and contracts by time to time.  
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2. Non-specific or aspecific (according to European rheumatologic classification, we sort any 
type of low back pain which is not being verified as disc herniation, discopathy, protrusion of 
disc, originated from tumors, osteoporosis ) .Chronic low back pain: (LBP), also known as lower 
back pain or lumbago, is a common disorder involving the muscles and bones of the back. 
Duration of the pain may classify low back pain as acute (pain lasting less than six weeks), sub-
chronic (6 to 12 weeks), or chronic (more than 12 weeks). The condition may be further 
classified by the underlying cause as either mechanical, nonmechanical, or referred pain. In most 
episodes of low back pain, a specific cause is not identified or even looked for, with the pain 
believed to be due to mechanical problems such as muscle or joint strain. If the pain does not go 
away with conservative treatment or if it is accompanied by "red flags" such as unexplained 
weight loss, fever, or significant problems with feeling or movement, further testing may be 
needed to look for a serious underlying problem. In most cases, imaging tools such as X-ray 
computed tomography are not useful and carry their risks. Damaged intervertebral discs cause 
some low back pain, and the straight leg raise test is helpful to identify this cause. In those with 
chronic pain, the pain processing system may malfunction, causing large amounts of pain in 
response to non-serious events. Despite this, the use of imaging in low back pain has increased. 
The treatment of acute non-specific low back pain is typical with conservative measures: as the 
use of simple pain medications and the continuation of as much normal activity as the pain 
allows without bed rest. Chronic non-specific lower back pain needs more management for 
relieving permanent pain.  
 
Our objective performs an extended study of the OTM method for the Dupuytren's contracture 
(DuCo) and the chronic low back pain (cLBP), proving its support to the healthy homeostatic 
equilibrium, and its effective recognition of the deviations from the complex harmony, and treat 
selectively for improvement of regular functions.  
 
MATERIALS & METHODS  
 
We applied OTM with a specialized device called “Booster” (Oncotherm GmbH, Troisdorf 
Germany). The OTM methods are generally devoted for primer and metastatic malignancies, but 
Booster was developed for physiotherapies, using the effects and knowledge, which was 
collected for two decades in oncology. It is devoted to be applied in rheumatology, sports 
medicine, dermatology and analgesic therapy. The equipment is a table-top device, having 
precise tuning of the patient, fitting to the actual electric impedance of the targeted body-part. 
The maximal power is 80 W working with 6.78 MHz RF-frequency. We applied this equipment 
in complementary treatment with a modified acupuncture in Traditional Chinese Medicine 
(TCM) Our special acupuncture method [11] uses permanent triggering of the chosen 
acupunctural point even for days without taking care on the needle during in this long period of 
time. This permanent acupuncture method (PAM) well fits to the complementary applications 
like the treatment with Booster. The treatment was made for patients eligible for inclusion and 
exclusion criteria of the study.  
 
The study for selected diseases was performed according to Helsinki Declaration and local 
ethical approval. Rheumatologist outpatient's clinic made a patient selection. The period of study 
was 2012-2015.  
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Number of studied n=76 patients with DuCo, and n=155 patients with cLBP. The flow-chart of 
the present study is shown in fig. 1.  
 
The inclusion criteria for Dupuytren’s contracture (DuCo) were  
• diagnosed in Dupuytren’s contracture 
• Age  
• Stages N0, N1, N2  (above explained)  
• Physical status 
• Blood --- pressure ---- rate---- PO2 
• Written consent 
 
The exclusion criteria were for patients, which were not fit to inclusion criteria. 
The method of study was to investigate whether progression of the disease could be stopped 
without side-effect together with an elevation of QoL of patients.  
According to the above criteria, we selected 76 patients suffering from Dupuytren’s contracture 
in different stages. Some typical disease shown on fig 1.  
 
 
 
 
	  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.1. The flow-chart of the present study. 
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  (Quality	  of	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Fig. 2.  Dupuytren's contracture N0, N1, N2 stages 
 
The selected patients in all stages received two times/week physiotherapy with the Booster using, 
30 W, 25 minutes, one course is four weeks (eight sessions), after ½ years it was repeated three 
times. Additional therapies were applied for Dupuytren’s cases: Quercetin, Bromelain, DMSO, 
MSM, Acetylcarnitin HCl, PABA, Nattokinase, Vitamin E (1940) Copper, Vitamin C, 
conventional continuous massage therapy. The primer outcome measurement was “top of plate 
test”, (see fig. 3.), a painless extension of palm. Second outcome measurements were QoL, VAS 
of patients.  
 
 
Fig.3. Table-top test. Patient places his hand on a flat surface (e.g. table). If the hand lies 
completely flat on the table, the test is considered negative. If the hand cannot be placed 
completely flat on the table, but there is a space between the table and a part of the hand as big as 
the diameter of a ballpoint pen, the test is considered positive, treatment may be indicated. 
Additionally, finger joints may become fixed and rigid.  
 
Questionnaire on pain and QoL was filled with all sessions during a physical examination. 
Visual Analog Scale (VAS), and also the “table-top test” were registered during all period of 
treatments.  
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In case of chronic low back pain (cLBP) the method of study was also to investigate whether 
progression of the disease could be stopped without side-effect together with an elevation of QoL 
of patients.  
 
The inclusion criteria for chronic low-back pain were  
• diagnosed in chronic low-back pain (cLBP), low back pain lasting more than four weeks 
• Age 20-75 
• Stage 
• Physical status 
• Blood -pressure rate- (normal) PO2,  
• Written consent 
 
The exclusion criteria were for patients which  
• did not fit to inclusion criteria  
• have ruptured disc herniation,  
• caudal syndrome, (with serious vegetative neurological symptom- as missing reflex of 
defecation, urination, which needs immediately neurosurgical intervention)  
• malignancy (bone metastasis from lung, breast, prostate, thyroid, among others),  
• infections (osteomyelitis; abscess). 
 
The patients eligible for criteria received a treatment with Booster 2-times/week, 30 W, 25 
minutes, one course is four weeks (8 sessions), after ½  years it was repeated three times. 
(example of the treatment is shown on Fig.4.)  
 
	  	   	  
Figure 4a              Figure 4b  
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Figure 4c Fig 4. Low back pain treatment in chronic pain  
 
 
The Booster electrode is applied to the painful local area (back) of the patient. Additionally, all 
patients received mesotherapy (neuraltherapy by local anaesthetic Procaine 0,5 %, 2-3 ml 
/session and acupuncture (permanent monofilament insertion one time/month according to TCM 
protocol and protocol of Neuraltherapy according to Hunecke). Example of the investigation is 
shown on Fig. 5. 
 
  
Figure 5a. Anatomical orientation of lumbar-sacral region, spine, muscles and tendons 
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Figure 5b  
 
 
       
5.1 Direction of Procain 0,5 % for low back pain   5.2. Direction of insertion of needle of      
                                                                                       neuraltherapy 
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5.3. Procedure of lumbar neural therapy: 1: orientation of needle first, 2. Deep arrival of ganglion 
 
Fig. 5.-5-3. “Lege artis” neural therapy (according to Hunecke) in chronic, degenerative 
syndromes on musculoskeletal system.	   Neural therapy (“neuraltherapy”), therapeutic local 
anesthesia (TLA), or therapeutic neural blockade, are common names for the diagnostic and 
therapeutic use of local anesthetics (LA). In contrast to the well-deﬁned and short-time use for 
analgesia in surgery, the neural therapy approach aims for long-term relief of pain and functional 
disorders. 
 
(Neural therapy- A review of the therapeutic use of local anesthetics, Stefan  Weinschenk a,b,∗a  
Department of Gynecological Endocrinology and Reproductive Medicine, University of 
Heidelberg, Germany,  b The HUNTER Group – Heidelberg University Neural Therapy 
Education and Research,  Germany) 
 
Questionnaire on pain and QoL was filled with all sessions during a physical examination. 
Visual Analog Scale (VAS), and was evaluated.  
 
RESULTS  
 
We recognized in N0 and N1st stage of Dupuytren’s cases a significant delay of progression, 
moderately in N2nd. No changes were observed in progressive stages after two years’ follow-up. 
According to delayed progression in VAS can be seen the result. (Fig. 6.) 
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Fig. 6. Results in Dupuytran’s contracture, (2013-2015).  
Study of the cLBP showed significant effect of cure & better results were achieved. We observed 
the most effective pain-block in cases of ischialgia, chronic lumbar disc degeneration, and cLBP 
in consequence of postoperative oedema. The VAS score was reduced significantly (Fig. 7.) 
Anecdotically we registered, that the when the regular activity was blocked due to cLBP was 
significantly reduced. We registered the reduce dose of analgesic pills after the treatments.  
 
 
 
Fig. 7. Results in chronic low back pain, (n=155) VAS (2013-2015)  
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DISCUSSION   
 
The targeted RF therapy was used complementary to comprehensive pharmacotherapy with the 
Booster device. The treatment with the device was well supported by the various medications, 
but importantly the pain killer analgesics were reduced gradually by time. The dominant effect of 
the Booster was the deep heating in the region where the electrode was positioned. The actual 
specific absorption rate (SAR) leads to vasodilatation in the target volume, that in turn, improves 
blood perfusion, and thus the drugs (and more oxygen) are transported to the treatment volume. 
The increased blood flow helps the higher concentration of the drug in the target as well as 
reduces the impedance of the drug through the walls of capillaries, and could help the cell-
membrane reaction and cellular influx of the drugs, together the increased chemical reaction rate 
due to the elevated temperature. The improvement was expected due to the increased fibroblast 
activity and increased capillary angiogenesis, increased nutrient concentration and well gained 
metabolic activity. The synergy of the field-dependent effects [12], (optimization of membrane 
stimulation and activation of signal channels, etc.) is also assumed. Increased reactions to heat 
and field exposure (mainly the development of membrane heat shock proteins, (mHSP), which 
would be liberated to extracellular fluid promoting apoptosis of damaged cells [13], increased 
venous and lymphatic flow causing changes in the physical properties of the tissue finally. The 
selection of cells did not occur, but the membrane raft heating was effective as expected in 
nanoheating processes [2], [3]. The temperature in the targeted volume was 38-39°C (moderate 
conventional hyperthermia), which is the optimum for immune-reactions too [14].   
 
Recognition of the distortions in the healthy tissue have some common principles and 
possibilities in TCM and OTM: the loss of complexity of the living organization is recognized by 
both methods, and the aim to reestablish the homeostatic equilibrium is common [15].  
 
We observed, that our special permanent acupuncture method well fits to the complementary 
applications of treatments with Booster. The synergy of the ancient knowledge and the high-tech 
state-of-art of the medical knowledge could be established by this research. The positive result of 
this study was the recognition to apply the RF heat therapy for non-malignant, but proliferating 
connective tissue diseases with a positive result.  
 
The limitation of this study is a lack of double-blind control and lack of “sham” application. We 
need further research in the future to clarify the exact undergoing process in selected disease 
group, but results show improvement and better QoL on regarded diseases. Therefore, it is 
advisable to use this physiotherapeutic method in the daily practice of mentioned disease after 
careful selection. [16,17]    
 
CONCLUSION   
 
OTM application is a useful, harmless additional complementary treatment for the management 
of selected diseases. Our objective which was giving western trained physicians clinical 
applications of new Oncothermia- Booster method is fulfilled. We recognized this equipment as 
a good physiotherapeutic complementary facility to accommodate accelerating interests in the 
modern complex treatment of western medicine together with TCM.  
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According to our experience, the "targeted radiofrequency-physiotherapy as Booster" application 
is free of side effects, harmless, well-tolerable by patients, easy to apply by the skilled operation. 
It is advised to consider that complementary treatment for selected diseases, introducing it into 
daily rheumatologic practice. Also, we recognized the less intake of medicaments in cases during 
sessions of low back pain, which is important to avoid unnecessary side effects of medicaments 
(NSAID).  
 
Abbreviations: OTH: Oncothermia, cLBP: chronic low back pain, TCM: Traditional Chinese 
Medicine, VAS: Visual Analog Scale, QoL: Quality of Life, DoCo: Dupuytren's contracture, RF: 
radiofrequency   
 
The present scientific contribution is dedicated to the 650th anniversary of the foundation 
of the University of Pécs, Hungary, which is the oldest renowned University in Hungary.  
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